ID   PM-LGSOC-01 luc-EGFP
AC   CVCL_ZE89
DR   cancercelllines; CVCL_ZE89
DR   Wikidata; Q98128639
RX   PubMed=32317693;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=32317693).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Firefly luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX32 ! PM-LGSOC-01
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
RX   PubMed=32317693; DOI=10.1038/s41598-020-63738-6; PMCID=PMC7174384;
RA   De Thaye E.A.Y., Van de Vijver K., Van der Meulen J., Taminau J.,
RA   Wagemans G., Denys H., van Dorpe J., Berx G., Ceelen W.,
RA   Van Bocxlaer J., De Wever O.;
RT   "Establishment and characterization of a cell line and patient-derived
RT   xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian
RT   carcinoma.";
RL   Sci. Rep. 10:6688-6688(2020).
//